| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma.
|
N Engl J Med
|
1996
|
3.30
|
|
2
|
Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group.
|
N Engl J Med
|
1997
|
3.03
|
|
3
|
Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells.
|
J Biol Chem
|
1986
|
2.88
|
|
4
|
Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen-induced resistance to xenobiotics in rats.
|
Proc Natl Acad Sci U S A
|
1986
|
1.71
|
|
5
|
Improving the therapeutic index of anthracycline chemotherapy: focus on liposomal doxorubicin (Myocet).
|
Breast
|
2009
|
1.09
|
|
6
|
Evolving characteristics of AIDS-related lymphoma.
|
Blood
|
2000
|
1.05
|
|
7
|
Interleukin 8 is an autocrine growth factor and a surrogate marker for Kaposi's sarcoma.
|
Clin Cancer Res
|
2001
|
0.99
|
|
8
|
Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin.
|
J Clin Oncol
|
1995
|
0.98
|
|
9
|
Intraperitoneal 5-fluoro-2'-deoxyuridine (FUDR) and (S)-leucovorin for disease predominantly confined to the peritoneal cavity: a pharmacokinetic and toxicity study.
|
Cancer Chemother Pharmacol
|
1995
|
0.92
|
|
10
|
Altered regulation of P-450IA1 expression in a multidrug-resistant MCF-7 human breast cancer cell line.
|
J Biol Chem
|
1988
|
0.90
|
|
11
|
High-dose cytosine-arabinoside and cisplatin regimens as salvage therapy for refractory or relapsed AIDS-related non-Hodgkin's lymphoma.
|
J Acquir Immune Defic Syndr
|
2001
|
0.89
|
|
12
|
Chemotherapy consisting of doxorubicin, bleomycin, vinblastine, and dacarbazine with granulocyte-colony-stimulating factor in HIV-infected patients with newly diagnosed Hodgkin's disease: a prospective, multi-institutional AIDS clinical trials group study (ACTG 149).
|
J Acquir Immune Defic Syndr
|
2000
|
0.87
|
|
13
|
Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma.
|
J Clin Oncol
|
1999
|
0.86
|
|
14
|
Clinical aspects and management of AIDS-related Kaposi's sarcoma.
|
Eur J Cancer
|
2001
|
0.85
|
|
15
|
Chloroquine kinetics in the undernourished.
|
Eur J Clin Pharmacol
|
1983
|
0.84
|
|
16
|
Emerging treatments for epidemic (AIDS-related) Kaposi's sarcoma.
|
Curr Opin Oncol
|
1998
|
0.83
|
|
17
|
Kaposi sarcoma is a therapeutic target for vitamin D(3) receptor agonist.
|
Blood
|
2000
|
0.81
|
|
18
|
Effect of food on bioavailability of chloroquine.
|
Eur J Clin Pharmacol
|
1982
|
0.81
|
|
19
|
Immunotoxin combined with chemotherapy for patients with AIDS-related non-Hodgkin's lymphoma.
|
Cancer
|
1998
|
0.81
|
|
20
|
Incidence and management of AIDS-related lymphoma.
|
Oncology (Williston Park)
|
2001
|
0.80
|
|
21
|
Intraperitoneal 5-fluoro-2'-deoxyuridine with escalating doses of leucovorin: pharmacology and clinical tolerance.
|
Invest New Drugs
|
1994
|
0.80
|
|
22
|
Mitoguazone therapy in patients with refractory or relapsed AIDS-related lymphoma: results from a multicenter phase II trial.
|
J Clin Oncol
|
1997
|
0.79
|
|
23
|
Low dose methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine, and dexamethasone with zalcitabine in patients with acquired immunodeficiency syndrome-related lymphoma. Effect on human immunodeficiency virus and serum interleukin-6 levels over time.
|
Cancer
|
1996
|
0.77
|
|
24
|
All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study.
|
Leukemia
|
1994
|
0.77
|
|
25
|
A phase I/II trial of pixantrone (BBR2778), methylprednisolone, cisplatin, and cytosine arabinoside (PSHAP) in relapsed/refractory aggressive non-Hodgkin's lymphoma.
|
Leuk Lymphoma
|
2007
|
0.77
|
|
26
|
Effect of rice diet on chloroquine bioavailability.
|
Drug Nutr Interact
|
1983
|
0.75
|
|
27
|
Treatment of epidemic (AIDS-related) Kaposi's sarcoma.
|
Curr Opin Oncol
|
1997
|
0.75
|
|
28
|
Phase I study of human chorionic gonadotropin given subcutaneously to patients with acquired immunodeficiency syndrome-related mucocutaneous Kaposi's sarcoma.
|
J Natl Cancer Inst
|
1997
|
0.75
|